Tempus Ai

This study tests whether an artificial intelligence (AI) tool that reads electrocardiograms (ECGs) can help doctors find undiagnosed pulmonary hypertension in people with interstitial lung disease. About 900 adults with severe lung scarring will be randomly assigned to have their…

This study is for people with extensive stage small cell lung cancer. It aims to learn more about the disease by analyzing tumor tissue and blood samples over time. Researchers will look at genetic changes and other markers to see how they relate to treatment outcomes. The study …

This study is collecting blood and leftover tissue samples from 550 people with acute myeloid leukemia or follicular lymphoma. Researchers will analyze the samples to find genetic markers that may predict how well treatments work or why they stop working. The goal is to better un…

This study is gathering blood and tissue samples from 500 people with advanced head and neck cancer to look for genetic markers (biomarkers) that might predict how well treatments work. Participants continue their usual care while providing samples over time. The goal is to bette…

This study is for people with non-small cell lung cancer who have had or will have surgery to remove their tumor. Researchers will collect blood samples and health information over time to see how the cancer changes and whether simple blood tests can predict if the cancer will co…

This study is for 500 adults with cancer who are willing to give extra blood samples over time. Researchers will look for tiny bits of tumor DNA in the blood to see how cancer changes during and after standard treatment. The goal is to learn more about cancer, not to test a new t…

This study looks at whether a simple blood test can find tiny bits of cancer DNA left in the body after breast cancer treatment. Finding this DNA, called minimal residual disease, may help predict if the cancer will come back. The study will follow 900 people with different types…